BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26251144)

  • 21. Potential immunogenicity of adult T cell leukemia cells in vivo.
    Kurihara K; Harashima N; Hanabuchi S; Masuda M; Utsunomiya A; Tanosaki R; Tomonaga M; Ohashi T; Hasegawa A; Masuda T; Okamura J; Tanaka Y; Kannagi M
    Int J Cancer; 2005 Mar; 114(2):257-67. PubMed ID: 15551352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia.
    Kannagi M
    Int J Hematol; 2007 Aug; 86(2):113-7. PubMed ID: 17875523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients.
    Kozako T; Arima N; Toji S; Masamoto I; Akimoto M; Hamada H; Che XF; Fujiwara H; Matsushita K; Tokunaga M; Haraguchi K; Uozumi K; Suzuki S; Takezaki T; Sonoda S
    J Immunol; 2006 Oct; 177(8):5718-26. PubMed ID: 17015761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
    J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model.
    Ohashi T; Nagai M; Okada H; Takayanagi R; Shida H
    Retrovirology; 2008 Oct; 5():90. PubMed ID: 18840303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study.
    Suehiro Y; Hasegawa A; Iino T; Sasada A; Watanabe N; Matsuoka M; Takamori A; Tanosaki R; Utsunomiya A; Choi I; Fukuda T; Miura O; Takaishi S; Teshima T; Akashi K; Kannagi M; Uike N; Okamura J
    Br J Haematol; 2015 May; 169(3):356-67. PubMed ID: 25612920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HTLV-I viral escape and host genetic changes in the development of adult T cell leukemia.
    Furukawa Y; Tara M; Izumo S; Arimura K; Osame M
    Int J Cancer; 2006 Jan; 118(2):381-7. PubMed ID: 16052518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HTLV-1 Tax-specific memory cytotoxic T lymphocytes in long-term survivors of aggressive-type adult T-cell leukemia/lymphoma.
    Jo T; Noguchi K; Sakai T; Kubota-Koketsu R; Irie S; Matsuo M; Taguchi J; Abe K; Shigematsu K
    Cancer Med; 2022 Sep; 11(17):3238-3250. PubMed ID: 35315593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
    Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological risks of adult T-cell leukemia at primary HTLV-I infection.
    Kannagi M; Ohashi T; Harashima N; Hanabuchi S; Hasegawa A
    Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor immunity against adult T-cell leukemia.
    Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
    Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.
    Masaki A; Ishida T; Suzuki S; Ito A; Narita T; Kinoshita S; Ri M; Kusumoto S; Komatsu H; Inagaki H; Ueda R; Iida S
    Cancer Sci; 2018 Aug; 109(8):2383-2390. PubMed ID: 29845702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma].
    Utsunomiya A
    Rinsho Ketsueki; 2016; 57(10):2190-2198. PubMed ID: 27795530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
    Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M
    Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis.
    Ishikawa C; Nakachi S; Senba M; Sugai M; Mori N
    Carcinogenesis; 2011 Jan; 32(1):110-9. PubMed ID: 20974684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
    Narita T; Ishida T; Masaki A; Suzuki S; Ito A; Mori F; Yamada T; Ri M; Kusumoto S; Komatsu H; Miyazaki Y; Takatsuka Y; Utsunomiya A; Niimi A; Iida S; Ueda R
    J Immunol; 2014 Feb; 192(3):940-7. PubMed ID: 24363428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model.
    Nomura M; Ohashi T; Nishikawa K; Nishitsuji H; Kurihara K; Hasegawa A; Furuta RA; Fujisawa J; Tanaka Y; Hanabuchi S; Harashima N; Masuda T; Kannagi M
    J Virol; 2004 Apr; 78(8):3827-36. PubMed ID: 15047798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect.
    Shiratori S; Yasumoto A; Tanaka J; Shigematsu A; Yamamoto S; Nishio M; Hashino S; Morita R; Takahata M; Onozawa M; Kahata K; Kondo T; Ota S; Wakasa K; Sugita J; Koike T; Asaka M; Kasai M; Imamura M
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):817-23. PubMed ID: 18541202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy.
    Sakamoto H; Itonaga H; Sawayama Y; Kojima A; Chiwata M; Fujioka M; Kitanosono H; Horai M; Miyazaki T; Shiraishi H; Imaizumi Y; Yoshida S; Hata T; Yamano Y; Miyazaki Y
    Int J Hematol; 2021 May; 113(5):765-769. PubMed ID: 33423163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma.
    Suzuki S; Masaki A; Ishida T; Ito A; Mori F; Sato F; Narita T; Ri M; Kusumoto S; Komatsu H; Fukumori Y; Nishikawa H; Tanaka Y; Niimi A; Inagaki H; Iida S; Ueda R
    Cancer Sci; 2012 Oct; 103(10):1764-73. PubMed ID: 22735080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.